Gingival tissue inflammation mediators

Gingival tissue inflammation mediators are a complex collective of molecules—including cytokines (e.g., IL-1β, IL-6, IL-17, TNF-α, IFN-γ), chemokines (e.g., IL-8, MCP-1), lipid mediators (e.g., prostaglandins, leukotrienes, lipoxins), and proteolytic enzymes (e.g., matrix metalloproteinases)—produced by various cells such as epithelial cells, fibroblasts, macrophages, mast cells, and neutrophils during inflammatory states in the gingiva. These mediators function in immune cell recruitment, tissue destruction and repair, bone resorption, and the regulation of inflammation in both health and disease. In chronic conditions like periodontitis, dysregulation leads to persistent tissue degradation, bone loss, and can impact systemic health. Due to their heterogeneity and vital roles in both homeostasis and pathology, they are biological mechanisms rather than single molecular drug targets.

Other names

Periodontal inflammatory mediatorsGingival inflammatory cytokinesInflammatory mediators in gingiva

Drugs targeting these mediators work by inhibiting cytokine production (e.g., corticosteroids, NSAIDs), blocking cytokine/receptor interactions (e.g., anti-TNF, anti-IL-1, anti-IL-6 agents), inhibiting arachidonic acid pathway enzymes (e.g., COX blockers, NSAIDs), or modulating bone resorption signaling (e.g., anti-RANKL).